Molecule Details
| InChIKey | YQNQNVDNTFHQSW-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.19 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00507 |
|---|---|
| Drug Name | Nitazoxanide |
| CAS Number | 55981-09-4 |
| Groups | approved investigational vet_approved |
| ATC Codes | P01AX11 J01RA17 |
| Description | Nitazoxanide belongs to the class of drugs known as _thiazolides_. Nitazoxanide (NTZ) is a broad-spectrum anti-infective drug that markedly modulates the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, in ... |
Categories: Anti-Infective Agents Antibacterials for Systemic Use Antiinfectives for Systemic Use Antiparasitic Agents Antiparasitic Products, Insecticides and Repellents Antiprotozoals Sulfur Compounds
Cross-references: BindingDB: 50075050 ChEBI: 94807 CHEMBL1401 ChemSpider: 38037 D02486 PDB: NTI PharmGKB: PA164754874 PubChem:41684 PubChem:46507813 RxCUI: 31819 Therapeutic Targets Database: DAP001293 Wikipedia: Nitazoxanide ZINC: ZINC000003956788